Lataa...
The β-Lactams Strike Back: Ceftazidime-Avibactam
Gram-negative resistance has reached a crucial point, with emergence of pathogens resistant to most or all available antibiotics. Ceftazidime-avibactam is a newly approved agent combining ceftazidime and a novel β-lactamase inhibitor with activity against multidrug-resistant gram-negative bacteria....
Tallennettuna:
| Julkaisussa: | Pharmacotherapy |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4545577/ https://ncbi.nlm.nih.gov/pubmed/26289307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1622 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|